Escalon Medical Corp.
ESMC · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $2,400 | $1,057 | $1,854 | $938 |
| - Cash | $545,835 | $209 | $890 | $594 |
| + Debt | $255,059 | $525 | $890 | $1,205 |
| Enterprise Value | -$288,376 | $1,372 | $1,854 | $1,550 |
| Revenue | $12,046 | $11,982 | $12,180 | $10,703 |
| % Growth | 0.5% | -1.6% | 13.8% | – |
| Gross Profit | $5,511 | $5,146 | $5,481 | $4,607 |
| % Margin | 45.7% | 43% | 45% | 43% |
| EBITDA | $166 | -$58 | $524 | $365 |
| % Margin | 1.4% | -0.5% | 4.3% | 3.4% |
| Net Income | $106 | -$125 | $457 | $18 |
| % Margin | 0.9% | -1% | 3.8% | 0.2% |
| EPS Diluted | 0.002 | -0.024 | 0.034 | 0.002 |
| % Growth | 108.4% | -170.9% | 1,304.2% | – |
| Operating Cash Flow | $380,725 | -$603 | $325 | -$1,050 |
| Capital Expenditures | $0 | -$40 | -$14 | $0 |
| Free Cash Flow | $380,725 | -$643 | $311 | -$1,050 |